Lv41
420 积分 2025-07-05 加入
Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the Phase III FUTURE 5 study
2小时前
已完结
Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5‐year results from the randomized placebo‐controlled TRANSFIGURE study*
2小时前
已完结
Effect of secukinumab on the clinical activity and disease burden of nail psoriasis: 32‐week results from the randomized placebo‐controlled TRANSFIGURE trial
2小时前
已完结
The next quantum leap forward? Bimekizumab for psoriasis
8小时前
已完结
Difficult-to-Manage Axial Spondyloarthritis According to ASAS Criteria in Reuma-Check Cohort: Frequency, Predictive Factors, and Treatment Patterns
14天前
已完结
Systemic Psoriasis: From Molecular Mechanisms to Global Management Strategies
23天前
已完结
Skin Inflammation, Systemic Inflammation, and Cardiovascular Disease in Psoriasis
23天前
已完结
Defining On-Treatment Remission in Plaque Psoriasis
2个月前
已完结
Treatment of Severe Palmoplantar Pustular Psoriasis With Bimekizumab
2个月前
已完结
皖公网安备34019202002308
